Cited by 42Multiple Sclerosis Research StudiesNeuroinflammation and Neurodegeneration MechanismsNeurogenesis and neuroplasticity mechanisms

Brain lipid binding protein (FABP7) as modulator of astrocyte function

Open access
KIPP, M., CLARNER, T., GINGELE, S., POTT, F., AMOR, S., VAN DER VALK, P., BEYER, C.·2011·Physiological Research

Abstract

Over a century ago, hyperplasia and hypertrophy of astrocytes was noted as a histopathological hallmark of multiple sclerosis and was hypothesized to play an important role in the development and course of this disease. However until today, the factual contribution of astrocytes to multiple sclerosis is elusive. Astrocytes may play an active role during degeneration and demyelination by controlling local inflammation in the CNS, provoking damage of oligodendrocytes and axons, and glial scarring but might also be beneficial by creating a permissive environment for remyelination and oligodendrocyte precursor migration, proliferation, and differentiation. Recent findings from our lab suggest that brain lipid binding protein (FABP7) is implicated in the course of multiple sclerosis and the regulation of astrocyte function. The relevance of our findings and data from other groups are highlighted and discussed in this paper in the context of myelin repair.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.33549/physiolres.932168

Cites

83 of 83 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Expression of FABP7 was induced in activated astrocytes after cuprizone-induced acute demyelination, whereas expression of this marker and the extent of astrogliosis was diminished after chronic demyelination.

    “Recently, the expression of the radial glia cell marker fatty acid binding protein 7 (FABP7) was found to be induced in activated astrocytes after cuprizone-induced acute demyelination whereas expression of this marker and the extent of astrogliosis was diminished after chronic demyelination (Kipp et al., 2011a).”

    From Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned (2014) · cites this paper as Kipp et al., 2011a

    The sections on cuprizone-induced demyelination and FABP7 expression report abundant FABP7 in the acutely demyelinated corpus callosum and identify FABP7-positive, GFAP-positive astrocyte-like cells after acute treatment (page unavailable). The paper compares remyelination after acute and chronic treatment, but our copy does not report diminished FABP7 expression or diminished astrogliosis after chronic demyelination. (LLM, conf=0.85)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
KIPP, M., CLARNER, T., GINGELE, S., POTT, F., AMOR, S., VAN DER VALK, P., & BEYER, C.
Affiliations
  • RWTH Aachen University (DE)
  • Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
  • Queen Mary University of London (GB)
Corresponding author
KIPP, M.
Venue
Physiological Research
Published
2011-10-15
Volume
60
Issue
Suppl 1
Pages
S49-S60
ISSN
  • 0862-8408 (ISSN-L)
  • 1802-9973
OpenAlex
W2117761392
Cited by
42
References
83
Citations by year
2026: 2 · 2025: 4 · 2024: 1 · 2023: 5 · 2022: 3 · 2020: 3 · 2019: 5 · 2017: 3 · 2016: 2 · 2015: 4 · 2014: 5 · 2013: 2 · 2012: 1
FWCI
0.40
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • Physiological Research (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Pure Amsterdam UMC (publishedVersion)
  • Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
  • Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam) (submittedVersion)
  • RWTH Publications (RWTH Aachen) (submittedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
Topics
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Multiple Sclerosis Research Studies
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
Keywords
FABP7, brain lipid-binding protein, astrocytes, multiple sclerosis, astrocyte hyperplasia, demyelination, remyelination, oligodendrocyte precursor cells, glial scar, neuroinflammation
MeSH terms
Fatty Acid-Binding Protein 7, Animals, Astrocytes, Carrier Proteins, Cuprizone, Demyelinating Diseases, Disease Models, Animal, Humans, Multiple Sclerosis, Myelin Sheath, Nerve Tissue Proteins, Signal Transduction, Tumor Suppressor Proteins, Fatty Acid-Binding Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review